Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this ...

On Saturday, the Juice hitmaker took to Instagram to share a video of herself modeling a sexy piece of swimwear from her ...

A current weight-loss and diabetes drug has become a surprise candidate for migraine treatment, with a new pilot study ...

An expert has revealed the potential harm you could cause to your body if you pause taking Ozempic, then resume again.

For more health information, please see recent studies about Vitamin D that may reduce dangerous complications in diabetes ...

Gov. Maura Healey signed the new fiscal year's $61 billion operating plan on Friday, marking the earliest the state has ...

GLP-1 weight loss patches are everywhere but do they actually work as these trendy patches promise Ozempic-like results ...

Lizzo has shown off her dramatic weight loss in a new Instagram before-and-after post - and fans are all saying the same ...

Harnessing the power of a metabolite produced in the kidneys and absorbed from certain foods can mimic the health benefits ...

Improving access and affordability could be transformative for public health, given that about 88% of Americans are ...

The first study to put two GLP-1 weight loss drugs head-to-head found Zepbound helped people lose more weight than Wegovy.

VK2735 shows strong early weight loss data, positioning Viking Therapeutics as a potential third major player in the booming GLP-1 obesity drug market. Learn more on VKTX stock here.